White, KL; Robinson, JE; Zhu, H; DiBerto, JF; Polepally, PR; Zjawiony, JK; Nichols, DE; Malanga, CJ; Roth, BL. The G Protein-biased κ-opioid receptor agonist RB-64 is analgesic with a unique spectrum of activities in vivo J. Pharmacol. Exp. Ther., 18 Nov 2014, 352 (1), 98-109. 1.1 MB. https://doi.org/10.1124/jpet.114.216820
Baker, LE. Hallucinogens in drug discrimination In Behavioral Neurobiology of Psychedelic Drugs; Halberstadt, AL; Vollenweider, FX; Nichols, DE, Eds., Springer, 1 Jan 2017; pp 201-219. 342 kB. https://doi.org/10.1007/7854_2017_476
Kavanagh, PV; Power, JD. New psychoactive substances legislation in Ireland – Perspectives from academia Drug Test. Anal., 1 Jul 2014, 6 (7-8), 884-891. 1.2 MB. https://doi.org/10.1002/dta.1598
MacLean, KA; Johnson, MW; Reissig, CJ; Prisinzano, TE; Griffiths, RR. Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects Psychopharmacology, 8 Nov 2012, 226 (2), 381-392. 275 kB. https://doi.org/10.1007/s00213-012-2912-9
Shulgin, AT. Basic Pharmacology and Effects In Hallucinogens. A Forensic Drug Handbook; Laing, R; Siegel, JA, Eds., Academic Press, London, 24 Apr 2003; pp 67–137. 6.3 MB.
Addy, PH. Acute and post-acute behavioral and psychological effects of salvinorin A in humans Psychopharmacology, 1 Mar 2012, 220 (1), 195–204. 193 kB. https://doi.org/10.1007/s00213-011-2470-6 #Salvinorin A
Phipps, SM; Grundmann, O. Pharmacology and structure-activity relationship of natural products with psychoactive effects from Salvia divinorum, Mitragyna speciosa, and Ayahuasca In Stud. Nat. Prod. Chem.; , Elsevier, 1 Jan 2017; pp 1–44. 1.4 MB. https://doi.org/10.1016/B978-0-444-63930-1.00001-6 #1
Munro, TA. The chemistry of Salvia divinorum Ph. D. Thesis, University of Melbourne, Australia, 1 Jan 2006. 6.7 MB. #1a MS,NMR,IR,UV,TLC
Passie, T; Brandt, SD. Self-experiments with psychoactive substances: A historical perspective In New Psychoactive Substances: Pharmacology, Clinical, Forensic and Analytical Toxicology; Maurer, HH; Brandt, SD, Eds., Springer, Berlin, Heidelberg, 1 Jan 2018; pp 69-110. 563 kB. https://doi.org/10.1007/164_2018_177 #Salvinorin A
Hurd, J. Determination of Salvinorin A in a variety of Salvia species JCLIC, 1 Jan 2013, 23 (1), 15-23. 567 kB. GC,MS
Kikura-Hanajiri, R; Kawamura, M; Uchiyama, N; Ogata, J; Kamakura, H; Saisho, K; Goda, Y. Analytical data of designated substances (shitei-yakubutsu) controlled by the pharmaceutical affairs law in Japan, Part I: GC-MS and LC-MS Yakugaku Zasshi, 1 Jun 2008, 128 (6), 971–979. 1.4 MB. https://doi.org/10.1248/yakushi.128.971 #Salvinorin A Incorrect structures drawn. Corrected structures in errata page at end. GC,LC,MS,UV
Shulgin, AT. Salvia divinorum and Salvinorin-A receptor sites Ask Dr. Shulgin Online, Center for Cognitive Liberty & Ethics, 9 Jan 2002.
Shulgin, AT. Salvinorin A Ask Dr. Shulgin Online, Center for Cognitive Liberty & Ethics, 22 May 2002.
Shulgin, AT. Salvinorin A and the Analogue Act Ask Dr. Shulgin Online, Center for Cognitive Liberty & Ethics, 12 Jul 2002.